SEC Filing Summary: Nephros, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nephros, Inc. on April 30, 2007. The report discloses a material corporate governance event involving the resignation of a member of the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel change and does not contain financial statements or performance data.
Material Changes
On April 30, 2007, Donald G. Drapkin resigned from the Company's Board of Directors effective immediately to pursue other business interests. The filing states there were no disagreements between Mr. Drapkin and the Company regarding operations, policies, or practices. Following this resignation, the Board consists of eight members with one vacancy.
Outlook and Management Commentary
The Company expects to address the Board vacancy prior to its annual meeting of stockholders scheduled for May 22, 2007. The remaining directors, guided by the Nominating and Corporate Governance Committee, intend to either elect a new director or reduce the total number of directors constituting the Board. A press release announcing the resignation was issued on May 1, 2007.
Key Facts for Investor Verification
- Donald G. Drapkin resigned from the Board of Directors effective April 30, 2007.
- The Board currently has eight members and one vacancy.
- The vacancy is expected to be resolved before the annual stockholder meeting on May 22, 2007.
- The resignation was voluntary and not due to any disagreement with the Company.
- No financial performance data is included in this specific filing.